Market Players - U.S., Europe, and Asia Pacific Molecular Diagnostics Industry

Expanding the use of biomarkers

Players in the market are releasing new products, and the government is taking more measures. Demand for molecular diagnostic tests is rising.

The market for Molecular Diagnostics in the United States, Europe, and Asia-Pacific is anticipated to reach US$ 7,147 million in 2021 and grow at a CAGR of 10.7% from 2021 to 2028.

Prominent Companies in the U.S., Europe, and Asia Pacific Molecular Diagnostics Industry:

Abbott Laboratories:

1. Abbott produces and sells branded generic pharmaceuticals, adult and paediatric nutritional items, diagnostic tools, and testing kits.   Built in 1888. Head office in North Chicago, Illinois, USA.JETi (Sep 2021) Cephea Valve Technologies (Jan 2019), and St. Jude Medical (Apr 2016) are the most recent acquisitions.

Hologic, Inc.:

2. Hologic produces unique items for women's healthcare requirements. Bedford, Massachusetts serves as the home base for Hologic. Built in 1985. Company bought Bolder Surgical in October 2021.

Grifols, S.A.:

3. Grifols, situated in Spain, is a vertically integrated plasma derivative business that collects plasma before manufacturing and exporting plasma-derived goods. Headquartered in Barcelona, Spain; founded in 1909. Tiancheng (Germany) Pharmaceutical Holdings AG's whole share capital will be purchased by Grifols for EUR 1,091 million.

Qiagen N.V.:

4. DNA, RNA, and proteins can be extracted, purified, amplified, and interpreted using Qiagen's unique sample and assay technologies. The company's sales are split roughly evenly between molecular diagnostics and applications in the life sciences. Established in 1984. Headquarters in Germany's Hilden.  Verogen was just fully acquired by QIAGEN for $150 million in cash, which came from pre-existing reserves.

F.Hoffmann-La Roche Ltd.:

5.  Tasmar's rights to production, marketing, and distribution in the United States and a few other non-European Union areas. Parkinson's illness is managed with the medication tasmar. Roche plans to purchase the TIB Molbiol Group, with a closing anticipated for the fourth quarter of 2021.

Siemens Healthineers:

6. Founded in 2015. Headquarters at Germany's Erlangen. Diagnostic, therapeutic, laboratory, point-of-care, and clinical consulting services are all areas in which Siemens Healthineers AG operates. With the completion of the Varian acquisition, Siemens Healthineers has improved its standing as a full healthcare partner.

*Definition:

The process of identifying a disease by studying molecules, such as proteins, DNA, and RNA, in a tissue or fluid.